Quantity size:
0.2ml
Concentration:
1mg/ml 肿瘤抑制基因LATS1抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating 肿瘤抑制基因LATS1抗体 a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data 肿瘤抑制基因LATS1抗体 suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. [provided by RefSeq].
Also known as:
Large tumor suppressor homolog 1; Serine threonine protein kinase LATS1; WARTS; WARTS protein kinase; LATS1_HUMAN.
Specificity:
肿瘤抑制基因LATS1抗体 ●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human LATS1.
●
Predicted Molecular Weight: 124kDa.
肿瘤抑制基因LATS1抗体 Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl093Hu01白介素8抑制因子(IL8INH)多克隆抗体Polyclonal Antibody to Interleukin 8 Inhibitor (IL8INH)
kl448Hu01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)
kl448Mu01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)
kl448Ra01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)
kl448Rb51胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)
kl448Si01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)
kl448Ca01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)
kl448Po01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)
kl448Bo01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)
kl967Hu01激肽释放酶1(KLK1)多克隆抗体Polyclonal Antibody to Kallikrein 1 (KLK1)
kl967Mu01激肽释放酶1(KLK1)多克隆抗体Polyclonal Antibody to Kallikrein 1 (KLK1)
kl967Ra01激肽释放酶1(KLK1)多克隆抗体Polyclonal Antibody to Kallikrein 1 (KLK1)
kl697Hu01激肽释放酶10(KLK10)多克隆抗体Polyclonal Antibody to Kallikrein 10 (KLK10)
kl697Mu01激肽释放酶10(KLK10)多克隆抗体Polyclonal Antibody to Kallikrein 10 (KLK10)
kl697Ra01激肽释放酶10(KLK10)多克隆抗体Polyclonal Antibody to Kallikrein 10 (KLK10)
kl106Ge01半胱氨酸(Cys)多克隆抗体Polyclonal Antibody to Cysteine (Cys)
kl084Rb51瘦素(LEP)多克隆抗体Polyclonal Antibody to Leptin (LEP)
kl084Ca01瘦素(LEP)多克隆抗体Polyclonal Antibody to Leptin (LEP)
kl084Po01瘦素(LEP)多克隆抗体Polyclonal Antibody to Leptin (LEP)
kl084Bo01瘦素(LEP)多克隆抗体Polyclonal Antibody to Leptin (LEP)
kl084Cp01瘦素(LEP)多克隆抗体Polyclonal Antibody to Leptin (LEP)
kl084Eq01瘦素(LEP)多克隆抗体Polyclonal Antibody to Leptin (LEP)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话